🇺🇸 FDA
Patent

US 8575119

2′-chloroacetylenyl substituted nucleoside derivatives

granted A61KA61K31/015A61K31/427

Quick answer

US patent 8575119 (2′-chloroacetylenyl substituted nucleoside derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/015, A61K31/427, A61K31/7056, A61K31/706